Clinical Trial Update: Fluorescent Imaging of Nerves With Illuminare-1 During Surgery [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating Illuminare-1 for fluorescent nerve imaging during prostate cancer surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma

Drugs mentioned

• Illuminare-1

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Adenocarcinoma | Phase 1 | Status: COMPLETED